Skip to content

GIN-CRC-Pareto: A graph-based pareto-optimized multi-task learning framework to identify miRNA-target interactions in colorectal cancer.

Unknown authors
Sep 2026 · Journal of Biomedical Informatics · pp. 105099 · 0 citations · 43 references
Medicine

TL;DR

GIN-CRC-Pareto, a graph-based, Pareto-optimized multi-task learning framework that simultaneously predicts miRNA-mRNA binding pairs, identifies seed match pairings, and classifies seed match subtypes, provides an effective and scalable approach for comprehensive identification of miRNA-target interactions in CRC.

Abstract

Background

Colorectal cancer (CRC) ranks as the third highest incidence among malignancies for human and the second most common cause of cancer-related mortality in the United States. Accumulating evidence has established microRNAs (miRNAs) as critical regulators of cancer development and therapeutic response. Understanding miRNA-mRNA interactions is critical for elucidating the molecular mechanisms driving CRC and other malignancies. However, accurately modeling miRNA-mRNA interactions and their binding patterns remains challenging.

Methods

In this study, we proposed GIN-CRC-Pareto, a graph-based, Pareto-optimized multi-task learning framework that simultaneously predicts miRNA-mRNA binding pairs, identifies seed match pairings, and classifies seed match subtypes. By leveraging the power of graph neural networks and Pareto-optimized gradient balancing strategy, GIN-CRC-Pareto dynamically adjusted the task weights during training to optimize each task without compromising the others.

Results

Experimental results demonstrated that our framework consistently outperforms traditional deep learning models and existing state-of-the-art tools across multiple evaluation metrics, with 0.909 in accuracy, 0.909 in precision and 0.969 in AUC in the miRNA-mRNA binding pairs prediction task. Furthermore, transfer learning experiments on external datasets indicate strong generalizability of the framework for identifying miRNA-target interactions across multiple cancer types.

Conclusions

The proposed framework provides an effective and scalable approach for comprehensive identification of miRNA-target interactions in CRC, with the potential to serve as a scalable and generalizable tool across diverse cancer types, ultimately facilitating the development of miRNA-based therapeutics for cancer treatment.

View source

Similar papers

Sep 2026

Leakage-controlled benchmarking of multi-omics patient-graph construction for pan-cancer tumor-type classification and prognosis analysis.

Findings show that patient-graph construction is a key design choice in pan-cancer multi-omics learning and that leakage-controlled evaluation is essential for reliable and biologically informative benchmarking in computational oncology.

Sandhya Gubbala, Santhosh Amilpur, Chandra Mohan Dasari · 0 citations
Open access Aug 2026

A Biologically Informed Heterogeneous Graph Neural Network for Multi-Task Prediction of ncRNA–Metastasis–Cancer Interactions

Metastasis involves context-dependent molecular interactions in which non-coding RNAs, particularly miRNAs and circRNAs, play important regulatory roles. However, existing computational approaches generally do not jointly represent cancer type, metastatic event, and cancer-specific metastatic context. We developed a co...

F. Midjani, Mohammadreza Shaghouzi, Amirhossein Dehqan Banadaki et al. · 0 citations
Open access Aug 2026

TargetPrior: a miRNA-signature embedded evolutionary learning framework for prioritizing drug targets in acute myeloid leukemia

TargetPrior is presented as a computational proof-of-concept for generating prioritized therapeutic hypotheses, rather than as a universal target-discovery solution, and showed stronger early-rank retrieval than network-only and statistical approaches.

Ting-Yu Chen, Shinn-Ying Ho · 0 citations
Review Open access Aug 2026

Graph neural networks for multi-scale gene-drug interaction modeling in cancer: applications, challenges, and therapeutic opportunities for breast cancer drug resistance

Breast cancer drug resistance remains a major clinical challenge driven by complex genetic, signaling, and microenvironmental interactions. Conventional machine learning and deep learning represent genes, drugs, and patients as independent feature vectors, limiting their ability to capture biological relationships gove...

Priyanshu Das, Md. Jarifur Rahman, Sowhanur Rahman Nirob et al. · 0 citations
Sep 2026

Multi-view Graph Learning Framework with Spectral Encoding and Sparse Cross-Attention for miRNA-Drug Association Prediction.

Experimental results show that MVGSCA effectively integrates heterogeneous biological information and achieves superior prediction performance, offering valuable insights into cancer resistance mechanisms and supporting drug discovery efforts.

Ru Nie, Ying Fu, Zheng-Wei Li et al. · 0 citations
2026

Graph Neural Networks for Cancer Driver Gene Prediction: From Fundamentals to Applications.

This chapter provides a comprehensive technical protocol for predicting CDGs using a Graph Convolutional Network (GCN) and guides the reader through hyperparameter optimization, model training, and performance evaluation, while discussing practical considerations related to generalization, computational cost, and inter...

Renan Soares de Andrades, M. Recamonde-Mendoza · 0 citations

Related blog posts

Microsoft Research Blog Jul 13, 2026

Verifying Rust cryptography in SymCrypt, from standards to code

Cryptographic code supports vital protections in modern computing systems. Learn how a new method helps verify code as developers write it while preserving speed and adaptability as it gets implemented and evolves. The post Verifying Rust cryptography in SymCrypt, from standards to code appeared first on Microsoft Research.

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.